levocarnitine/b12/semaglutide Troubling Findings in Study of GLP-1 Compounders Boost GLP-1 Tolerance and Weight-Loss

What Did The Study Find

The GI symptomsnausea, vomiting, diarrhea, constipation, delayed gastric emptyingare present with both drugs and follow a similar dose-escalation pattern

If you experience side effects that are too challenging, there may be alternative treatments to consider

Daily Protein Targets While on Semaglutide or Tirzepatide A practical starting point is 0.8 to 1.0 grams of protein per pound of your goal body weight, or 1.6 to 2.2 grams per kilogram

These tumours arise because the glp-1(gf) allele prevents proper GSC differentiation, such that when these cells reach the proximal gonad, where another notch ligand (APX-1) is present, they begin to proliferate again 22

Insulin sensitivity, food intake, and cravings with premenstrual syndrome: A pilot study